Pharmacokinetics of Intravenously (DIZ101), Subcutaneously (DIZ102), and Intestinally (LCIG) Infused Levodopa in Advanced Parkinson Disease.
Filip BergquistMats EhrneboVincenzo DonadioAnders JohanssonFredrik LundinPer OdinPer SvenningssonFredrik HanssonLeif BringElias ErikssonNil DizdarPublished in: Neurology (2022)
ClinicalTrials.gov Identifier: NCT03419806. Registration first posted 5 Feb 2018, first patient enrolled 16 Feb 2018. Link to registration.